Explore the Regulatory Expectations for Rare vs. Non-Rare Diseases
Time: 2:00 pm
day: Conference Day One
Details:
- Discuss how cell and gene therapy products, disease characteristics, patient population, and therapeutic goals influence the regulatory expectations
- Understand how regulatory agency’s approach for rare vs non-rare diseases
- Explore strategies to effectively demonstrate safety and efficacy in rare vs non-rare diseas
